A SEVERE CASE OF COVID-19 THAT DEVELOPED ENCEPHALITIS AND TREATED SUCCESFULLY WITH IV IMMUNOGLOBULINS

Abstract

Neurologic manifestations of COVID-19 have attracted widespread attention. Though the respiratory system is the primary target of SARS-CoV2, it is now increasingly recognised as a neuropathogen. Clinical features range from mild lethargy to deep coma and evidence of focal or diffuse neurologic signs and symptoms. The majority of patients with encephalitis are in critical condition. We report here a case of COVID-19-related encephalitis who developed persistent drowsiness 11 days after admission. The patient recovered well upon treatment with intravenous immunoglobulins (IVIg).